Bethanechol

Régine Béliard Veillard, Pharm.D., BCACP TTS, Stacy Elder Dalpoas, Pharm.D., BCPS, Lipika Samal, M.D.

INDICATIONS

FDA

  • Urinary Retention: Treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention

NON-FDA APPROVED USES

  • Neurogenic bladder
  • Gastroparesis
  • Alzheimer’s disease
  • Gastric reflux
  • Gastric atony or adyamic ileus
  • Erectile dysfunction
  • Motion sickness
  • Stuttering
  • Treatment of disabling anticholinergic adverse effects or anticholinergic syndrome from medications such as tricyclic antidepressants

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: February 6, 2022